. Normal homeostasis and healing responses. In normal homeostasis a balance between proliferation and cell death maintains the tissue structure and function. Healing after acute injury can occur by regeneration, that restores normal tissue structure, or repair with deposition of collagen fibers and scar formation.
SCs and their niches
Self-renewal and differentiation of ASC are supported by two types of cell division known as symmetric and asymmetric (Morrison & Kimble, 2006) . With symmetric division both the daughter cells acquire similar fates, while the asymmetric division, a fundamental and nearly universal mechanism for the generation of cellular diversity and pattern, gives rise to daughter cells with dissimilar fates. Divergent fates in daughter cells may be recognized by various characteristics: (i) morphological, such as cell size and shape; (ii) molecular, such as the segregation of proteins into only one daughter cell; or (iii) behavioural, such as the subsequent descendant types produced by either of the daughter cells. One mechanism for fate determination of daughter cells following symmetric and asymmetric cell divisions is the partitioning of fate-determining molecules during mitosis of the mother cell (Tajbakhsh et al., 2009) . The idea that specific molecules can be partitioned unequally to daughter cells and behave as fate determinants had been hypothesized over a century earlier, following observations of cell divisions in simple organisms. When an intrinsic mechanism is used, cells establish an axis of polarity, orient the mitotic spindle along this axis and localize cell fate determinants to one side of the cell. During cytokinesis, determinants are then segregated into one of the two daughter cells where they direct cell fate (Betschinger & Knoblich, 2004) . However, this hypothesis was only experimentally validated a little under two decades ago, with the identification of the first asymmetrically segregated cell fate determinant -Numb (Rhyu et al., 1994) . 
Wnt signaling pathway
The Wnt signaling pathway is a highly conserved developmental pathway, and orchestrates development and morphogenesis in many different tissues. Wnt proteins are secreted proteins, that bind to receptors of the Frizzled family (FZD) (Wodarz & Nusse, 1998) , of which 10 members were found, and several coreceptors such as lipoprotein receptor-related protein (LRP)-5/6, (Pinson et al., 2000) Ryk, or Ror2 (Logan & Nusse, 2004) . Wnt signals can be transduced to the canonical, or Wnt/β-catenin, pathway and to the noncanonical, or β-catenin independent, pathway.
Canonical Wnt signaling pathway
The canonical Wnt pathway involves the multifunctional protein -catenin (MacDonald et al., 2009 ). In the absence of Wnt, -catenin is targeted to a multimeric destruction complex with adenomatous polyposis coli (APC) and Axin and is phosphorylated by casein kinase 1α, followed by phosphorylation by glycogen synthase kinase (GSK)3 (Fig.34) (Ikeda et al., 1998) . This phosphorylation targets -catenin for ubiquitination and degradation by the proteasome. The binding of Wnt ligands to the FZD receptors results in the disassembly of the destruction complex and the stabilization of -catenin. This process also involves the protein dishevelled (DVL). Cytoplasmic -catenin accumulates and is eventually imported into the nucleus, where it serves as a transcriptional coactivator of transcription factors of the TCF/LEF family (Arce et al., 2006) . TCF/LEF target genes are then involved in regulating cell proliferation, SC maintenance, or differentiation.
Noncanonical Wnt signaling pathway
Different noncanonical Wnt signals are transduced through FZD receptors and coreceptors. Depending on the major intracellular mediators used, those are called the Wnt/JNK (Veeman et al., 2003) or Wnt/calcium pathway (Fig. 3) . The core element of the Wnt/JNK pathway (or planar cell polarity -PCP-pathway) includes the activation of small GTPases of the rho family, such as rac, cdc42, and rhoA. The GTPases can activate more downstream mediators like JNK or rho kinase (ROK). In this branch, Dvl is also recruited by a FZD receptor and promotes the asymmetrical localization of the PCP core proteins within the cell (Montcouquiol, et al. 2006) . The asymmetrical subcellular localization of these elements in an epithelial sheet directs cytoskeletal reorganization. The same mechanism is used in mesenchymal cells to direct cell movement and migration during gastrulation (convergent and extension movements) (Roszko, et al., 2009 ). The existence of the Wnt/calcium pathway was hypothesized because injection of RNA coding for certain Wnts or FZD into early zebrafish embryos triggered intracellular calcium release (Slusarski et al., 1997) and loss of Wnt-11 or Wnt-5A function resulted in reduced intracellular calcium signaling (Eisenberg & Eisenberg, 1999; Westfall et al., 2003) . This finding was subsequently expanded by the observation that the Wnt-induced release of intracellular calcium is sufficient to activate different intracellular calcium-sensitive enzymes such as protein kinase C, PKC (Sheldahl et al., 1999) , calcium-calmodulindependent kinase II, CamKII (Kuhl et al., 2000) and the calcium-sensitive phosphatase calcineurin (Saneyoshi et al., 2002) . Through calcineurin the Wnt/calcium pathway connects to NFAT (nuclear factor of activated T cells) transcription factor and gene expression.
Presently, a series of recent findings clearly indicate that different Wnt signaling pathways are simultaneously active within the same cell type, supporting the idea that Wnt pathways are highly connected to form a Wnt signaling network. This network seems to be activated by either one or more ligands acting on a certain cell type (Kestler & Kuhl, 2008) .
Wnt signaling inhibitors
Secreted frizzled-related proteins (SFRP1, 2, 3, 4, 5), WIF1, DKK1, -2, -3, and -4 are secretedtype Wnt signaling inhibitors. WIFs and SFRPs can directly bind to Wnt proteins in the extracellular space, thereby affecting receptor occupancy and, ultimately, the cellular response (Bovolenta et al., 2008) . DKK1 is among the best-characterized inhibitors of the canonical Wnt pathway. DKK1 itself is a target gene of Wnt/ -catenin signaling, thereby establishing a negative-feedback loop (Niida et al., 2004) . There are two possible mechanisms by which DKK1 inhibits -catenin signaling. One possible mechanism is that DKK1 prevents the formation of Wnt-FZD-LRP6 complexes on the cell surface by binding to LRP6 (Seto et al., 2006) . Another possibility, which is related to the internalization of LRP6, is that DKK1 binds to another class of receptor, Kremen (Krm). In this model, the binding of DKK1 to LRP6 and Krm results in the formation of a ternary structure and induces rapid endocytosis and the removal of LRP6 from the plasma membrane, and thereby attenuates -catenin signaling (Mao et al., 2002) .
Hematopoietic SCs
In adult mammals, HSCs form a rare population of multipotent SCs that reside primarily in the bone marrow (BM). They have the capability to both self-renew and constantly give rise to lineage-specific progenitor cells and effector blood cells that perform the physiological functions of the hematopoietic system. Blood cells can be classified into various cell types, from the myeloid (monocytes and macrophages, neutrophils, basophils, eosinophils, erythrocytes, megakaryocytes/platelets, dendritic cells), and lymphoid lineages (T-cells, Bcells, NK-cells) (Liu et al., 2010) .
HSCs are functionally defined by their capacity to reconstitute the hematopoietic system of immunodeficient animals such as NOD/SCID mice or contribute to functional reconstitution in human transplant settings. HSCs can be identified and isolated by a combination of presence and absence of cell surface markers. The most commonly used combination is characterized by the positive expression of the tyrosine kinase receptor c-Kit (CD117) and the membrane glycoprotein Sca-1 (Okada et al., 1992) , together with the lack of markers of terminal differentiation (Ter119, Gr-1, Mac-1, B220, CD4 and CD8), collectively known as Lineage markers. The resulting c-Kit+ Sca-1+ Lin-population, is commonly referred to as KSL cells. More recently, an alternative method was described, using a signature of SLAM (Signaling lymphocyte activation molecule) family of cell surface molecules, CD150+ CD244-CD48- (Kiel et al, 2005) . This is the first family of receptors whose combinatorial expression precisely distinguishes HSCs from hematopoietic progenitor cells (HPC).
The BM microenvironment -also called niche-plays an important role in the regulation of self-renewal and differentiation of HSCs. It is composed of different types of cells and structures surrounding the bone, which regulates the fate of hematopoietic cells through direct or indirect means, facilitating a stable generation of all the blood cells needed in a steady state situation. But the niche also adapts in times of hematopoietic stress. A failure to maintain a strict regulation of the hematopoietic cells can lead to a variety of malignancies such as leukemia, the most common form of cancer in humans (Renstrom et al., 2010) .
Notch pathway as a regulator of HSC behavior
All Notch receptors and ligands are expressed on HSCs (Singh et al., 2000) and it is now well established that Notch signaling is essential for the production of HSCs during embryogenesis. However, its role in subsequent stages of mammalian HSC development is still controversial (Liu et al, 2010; Radtke et al., 2010) .
In adult hematopoiesis, activation of Notch signaling has been reported to promote HSCs self-renewal, proliferation and differentiation in vitro and in vivo, and in both mice and humans. Constitutive expression of NICD by HSCs, leading to the constitutive activation of the Notch pathway, enhances proliferation and consequently delays hematopoiesis. Conversely, it inhibits differentiation in response to various cytokines, mostly under myeloid promoting conditions (Carlesso et al, 1999) . Several reports show that HSCs stimulated with soluble or membrane-bound Notch ligand Delta 1 (Karanu et al, 2001) or Jagged1 (Karanu et al. 2000) increase in expansion potential in vitro and in reconstitution capacity in vivo. Although these gain-of-function studies show an important role for Notch in expanding the HSC pool, they do not prove that Notch is essential for post-natal hematopoiesis. The controversy arises from several loss-of-function studies in mice that did not fully support the previous conclusions. In particular, inactivation of Notch receptors (Notch1, Notch2), ligands (Jagged1) or downstream effectors (CSL/RBPJ, Mastermind-like1) does not impair HSC function (Cerdan & Bhatia, 2010) . Additional studies failed to identify a protective role for Notch when HSCs were exposed to oxidative stress. Taken together, these results show that Notch signaling is not a major regulator of adult HSC maintenance in vivo. Downstream of HSCs, Notch signaling plays a critical role in cell fate decision of a variety of oligopotent progenitor cells in the hematopoietic system, such as in T-cell development. Inactivation of Notch signaling in HPCs results in early blockade of T-cell lymphopoiesis, due to a failure in commitment to the T-cell lineage. Transgenic mice with a conditional deletion of Notch1 do not develop T-cells but develop ectopic B-cells in the thymus, while immunodeficient mice expressing a constitutively active form of Notch1 develop ectopic T-cells in the bone marrow (BM) but no B-cell (Tanigaki & Honjo, 2007) . Additionally, Notch1 signaling is necessary at various stages of T-cell development, such as progression through thymocyte maturation, regulation of T-cell Receptor (TCR-) gene rearrangement, regulation of lineage decisions between and lineages (Tanigaki & Honjo, 2007) .
Role of Notch in T-cell leukemia
The pathological role for a deregulated Notch signaling was first described in a rare human T-cell acute lymphoblastic leukaemia/lymphoma (T-ALL), in which a t(7;9) chromosomal translocation results in the generation of a constitutively active, but truncated form of the Notch1 receptor named TAN1 (Translocation Associated Notch homolog) (Ellisen et al., 1991) . Evidence that constitutively active Notch1 is responsible for disease development was provided by murine BM reconstitution experiments. Irradiated mice transplanted with BM progenitors expressing activated forms of Notch1 developed clonal hematopoietic tumors characterized as T-ALL. Experiments performed using other truncated Notch isoforms, including Notch2 and Notch3, showed similar results. However, mice having a defect in Tcell development failed to produce tumors. These results reveal that Notch1 has a special oncotropism for T-cell progenitors (Radtke et al., 2010) . These findings became extremely relevant when a study of a large number of T-ALL patients revealed in more than 50% of them the presence of at least one gain-of-function mutation in the Notch1 receptor, emphasizing the oncogenic role of Notch (Weng et al., 2004) . Notch1 mutations found in T-ALL affect critical domains responsible for preventing the spontaneous activation of the receptor in the absence of ligand or for terminating Notch1 signaling in the nucleus.
Studies of the genes and pathways controlled by Notch in T-ALL identified Notch1 as a central regulator, promoting leukemia cell growth by multiple direct and indirect mechanisms ( Fig. 4) (Paganin & Ferrando, 2011) . Analysis of Notch1 expression in T-ALL showed that it acts as a direct transcriptional activator of multiple genes. Notch1 also promotes the expression of the MYC oncogene, which in turn further enhances its direct effect on anabolic genes and facilitates cell growth. Indeed, many of the anabolic genes directly controlled by Notch1 are also direct targets of MYC, creating a feed-forward-loop transcriptional network that promotes leukemic cell growth (Palomero et al., 2006) . Additionally, Notch1 facilitates the activation of the PI3K-AKT-mTOR signaling pathway, a critical regulator of cell growth and metabolism, via transcriptional downregulation of the PTEN tumor suppressor gene by Hes1, a transcriptional repressor directly downstream of Notch1 signaling . The mTOR signaling was suppressed in T-ALL cells upon inhibition of Notch signaling, illustrating the importance of this indirect mechanism of regulation. The transcriptional program activated by oncogenic Notch1 also has a direct effect on cell cycle progression, promoting of G1/S cell cycle progression in T-ALL. This effect is mediated in part by transcriptional upregulation of CCND3, CDK4 and CDK6. Moreover, Notch1 induces the transcription of the S phase kinase-associated protein 2 (SKP2), which mediate the proteasomal degradation of CDKN1B (p27/Kip1) and CDKN1A (p21/Cip1), promoting premature entry of the cells into S phase (Sarmento et al, 2005) . Notch1 can also modulate the survival of T-ALL cells by interacting with NF-κB, upregulating its activity by increasing expression of IκB kinase and upregulating both the expression and the nuclear localization of NF-κB. Inhibition of NF-κB in T-ALL can efficiently restrict tumor growth both in vitro and in vivo (Vilimas et al., 2007) .
In addition, Notch1 modulates the NFAT cascade through the activation of calcineurin, which is a calcium-activated phosphatase that is important for the activation and translocation of NFAT factors to the nucleus. Calcineurin inhibition resulted in T-ALL cell death, as well as tumor regression and prolonged survival of leukemic mice (Medyouf et al., 2007) . Finally, Notch1 regulates the activity of p53, lowering its expression through repression of the ARF-mdm2-p53 surveillance network. Attenuation of Notch signaling led to increase p53 expression and to tumor regression by inducing apoptosis (Beverly et al., 2005) . A strong body of evidence supports a central role of Notch1 in promoting cell metabolism, growth and proliferation, as well as in enhancing the activity of signaling pathways that reinforce these functions and also promote cell survival. These results suggest that blocking Notch1 signaling may reduce the self-renewal capacity of T-ALL cells and/or selectively affect the leukemia initiating cell population.
Only few Notch mutations have been reported in myelogenous leukemias, but it is unclear whether Notch aberrant expression is responsible for the disease.
Fig. 4. Genes and pathways controlled by Notch in T-ALL

Wnt pathway and HSC
In hematopoiesis, Wnt pathway activity is required in the BM niche to regulate HSC proliferation and preserve self-renewal capacity (Malhotra & Kincade, 2009) . Even though the role of canonical signaling on the regulation of adult hematopoiesis has been studied in great detail, controversy remains, possibly explained by differences in strength and duration of Wnt signaling or redundancy with other pathways. A role for Wnt signaling in hematopoiesis is supported by observations that Wnt ligands enhance proliferation of HSCs ex vivo (Van Den Berg et al, 1998) and that Wnt antagonists inhibit HSC proliferation and reconstitution. In particular, only short-term repopulation was reported using HSCs from normal mice cultured with Wnt3A Willert et al., 2003) . Subsequent studies reported that noncanonical Wnt5a inhibited canonical Wnt3a-mediated signaling to promote the maintenance of quiescent, functionally transplantable HSCs. In addition constitutively active nuclear -catenin signaling reduces HSC quiescence and blocks HSC differentiation (Kirstetter et al., 2006) . On the other hand, osteoblast-specific expression of Dkk1 results in increased HSC cycling and reduced regenerative capacity (Fleming et al, 2008) . These findings suggest that Wnt pathway activation in the niche limits HSC proliferation and preserves self-renewal. These observations suggest that fine-tuning of Wnt/ -catenin activity in the microenvironment is crucial for maintaining SC quiescence.
The canonical Wnt pathway has also been shown to be necessary for appropriate HSC development (Zhao et al., 2008) . In this model, Ctnnb1-/-bone marrow cells are deficient in long-term HSC maintenance and compete poorly against wild-type cells. However, experiments in adult HSC revealed that Ctnnb1 is dispensable for HSC maintenance in fully developed HSC (Koch et al., 2008) . This indicates differential requirements for self-renewal pathways in development versus maintenance of HSC.
In the context of development, genetic studies have demonstrated the requirement for canonical signaling in the formation of mesoderm (Kelly et al., 2004; Liu et al., 1999) . Recent advances have provided insights into the uniqueness of the biological functions of canonical and noncanonical pathways. It has been found that non-canonical and canonical Wnts affected different target populations and stages of hematopoietic development (Vijayaragavan et al., 2009) . Consistent with its previously defined role in human adult cells (Van Den Berg et al., 1998) , canonical signaling increased proliferation of blood committed progenitors when administered during the proper window of time during EB development. However, a short pulse of non-canonical signaling was necessary and sufficient to control exit of hESCs from the pluripotent state and subsequent entry into the mesendoderm/mesoderm lineages (Vijayaragavan et al., 2009) . Taken together, these findings provide the first evidence of a unique role for non-canonical signaling in early specification of hematopoiesis from hESCs, whereas canonical signaling affects the proliferation of cells already fated to blood. These studies provide a valuable model system for examining the possibility of chronological activation and interaction between noncanonical and canonical signaling in the cellular progression from mesoderm to blood. The controversial function of canonical signaling on the reconstituting capacity of adult HSCs, combined with these present findings in hESCs, underscores the importance of fine tuning the strength and duration of Wnt signaling towards therapeutically exploiting the balance between self-renewal and lineage commitment of HSCs.
However, there are conflicting reports on the requirement for Wnt/ -catenin signaling in basal hematopoiesis: conditional disruption of -catenin in adult HSCs does not affect their ability to self-renew and reconstitute hematopoietic lineages (Huang et al, 2009 ). In addition, although overexpression of stabilized -catenin increases immunophenotypic HSCs, this is associated with a loss of repopulating activity and hematopoietic failure in vivo (Kirstetter et al., 2006) , findings that appear incompatible with a positive role for -catenin in hematopoiesis. A general conclusion from these apparently conflicting reports is that the role of Wnt signaling in hematopoiesis is complex and context dependent (Staal & Sen,. 2008) . However, although the -catenin loss-of-function studies suggest that canonical Wnt signaling is not essential for basal hematopoiesis in adults, they do not rule out a possible role for the Wnt/ -catenin pathway under nonbasal conditions and are still compatible with gain-of-function experiments in which the pathway is activated.
Wnt signaling and malignant HSC
Stem cell quiescence is closely associated with protection from myelotoxic insults (Cheshier et al, 1999) . Similar to the role of tissue SCs in normal tissues, several cancers are also propagated by small populations of quiescent cancer stem cells (CSCs) that are resistant to both conventional chemotherapy and targeted therapies, and are retained and contribute to relapse following discontinuation of therapy (Dick, 2008) .
When Ctnnb1 was deleted contemporaneously with activation of BCR-ABL using retroviral infection and transformation of HSC, chronic myeloid leukemia stem cell (CML-LSC) failed to engraft in secondary recipient mice (Hu Y et al., 2009) . These experiments clearly indicate a pivotal role of Wnt signaling in CML-LSC development. More recently, Ctnnb1 has been investigated in the maintenance of already engrafted CML-LSC. In this clinically relevant setting, pharmacologic or genetic inactivation of Ctnnb1 after onset of the myeloproliferative disease acted synergistically with imatinib, reduced LSC numbers, and improved survival in a BM transplant model (Abrahamsson et al., 2009 ). Thus, despite its dispensability for adult HSC, CML-LSCs seem to retain dependency on canonical Ctnnb1 to maintain self-renewal capacity. In human disease, Ctnnb1 activation via the canonical Wnt pathway has been shown to occur in CML-blast crisis LSCs. Aberrant splicing of GSK3 appears to contribute to this hyperactivation in blast crisis samples (Abrahamsson et al., 2009) . Thus, there is growing evidence that canonical Wnt signaling is an attractive target pathway in the treatment of CML-LSC. Moreover, cell extrinsic inhibition of Wnt signaling through ectopic DKK1 expression impairs leukemia cell proliferation in vitro (Zhu et al., 2009 ).
Intestinal SCs
Homeostasis of the intestinal epithelium is m a i n t a i n e d b y a n intestinal SC (ISC) compartment that resides at the bottom of the crypt, safely far from the shear stresses and potentially toxic agents. These ISC are at the top of a cellular hierarchy and are crucial for the renewal of the differentiated progeny within the intestinal layer (Medema & Vermeulen, 2011) . Indeed, as they migrate out of their niche, they cease to proliferate and initiate differentiation into the different cell lineages of the mature villi: absorptive enterocytes, mucin-secreting-goblet cells, peptide hormone-secreting neuroendocrine cells, and microbicide-secreting Paneth cells. Until relatively recently, ISCs were a rather elusive entity at the bottom of the intestinal crypt, and the discovery of ISC markers has only partly detailed the organization of the intestinal crypt and villi. Briefly, the marker LGR5 identifies crypt base columnar cells (CBCC) located in between the Paneth cells at the crypt bottom (Barker et al., 2007) , whereas the markers BMI1 and TERT identify the +4 position in the crypt, just above the Paneth cells (Montgomery et al., 2011; Sangiorgi & Capecchi, 2008) . Knock-in constructs that allow expression of GFP and Cre from the Lgr5 locus show that LGR5 expression is confined to CBCCs, and that these cells give rise to the variety of epithelial cells present in crypts, proving that CBCCs function as ISCs as well (Barker et al., 2007 ). The existence of these different types of ISC remains a matter of debate and notably, remains to be determined whether and how BMI1+ +4 cells ISCs and LGR5+ ISCs relate to each other. Interestingly, recent data indicate that TERT-expressing ISCs can generate LGR5+ISCs (Montgomery et al., 2011) suggesting that these different ISC types may act in a hierarchical fashion. Regardless of this dispute about ISC identity, there is a consensus that ISCs reside in a niche that provides the cells with essentials signals such as Wnt, Notch and Hedgehog. Under normal circumstances, the Paneth cell signals dictate the size of the SC pool to maintain the total number of SCs within the niche constant. SCs may divide asymmetrically, so that one SC remains within the niche, resulting in self-renewal, whilst the other daughter cell gives rise to progenitor cells that can migrate up the crypt and become more differentiated as they reach the top. Alternatively, two recent studies (LopezGarcia et al., 2010; Snippert et al., 2010) support that SCs may divide symmetrically either forming two daughter SCs (leading to expansion) or two daughter non-stem progenitor cells (leading to extinction). Several pathways play a role in maintaining and regulating stem ISCs, including Wnt and Notch.
Notch signaling in intestinal epithelium
In the intestine, Notch activity determines lineage decisions between enterocyte and secretory cell differentiation. Several components of the Notch pathway are expressed in adult intestinal crypt cells, suggesting a role for Notch signaling in gene expression programs in immature proliferating compartment cells (Sander & Powell, 2004; Schroder & Gossler, 2002) . The first evidence that Notch signaling plays a role in cell-type specification in the intestine was reported in Hes1 knockout mice (Jensen et al., 2000) . The deletion of the Hes1 gene resulted in the generation of excessive numbers of goblet cells, enteroendocrine cells, and Paneth cells. Subsequently, it was shown that Math1 (mouse atonal homolog1), one of the genes repressed by Hes1, is required for the differentiation into the three secretory lineages, because the intestinal epithelium of Math1-mutant mice is populated only by absorptive cells (Yang et al., 2001) . These data suggest that the choice between the absorptive or secretory fate might be the first decision made by each progenitor cells, and that Hes1 and Math1 activated by Notch signal play opposite roles in this decision making. Recently, using the villin promoter to drive the expression of a constitutively active form of mouse Notch1 receptor, it was noticed an expansion of proliferating intestinal progenitor cells (Fre et al., 2005) . Moreover, Notch activation inhibited the differentiation of secretory cells in the mouse intestine, as there was a complete depletion of goblet cells, a marked reduction in enteroendocrine cells, and a low expression of early marker for Paneth cells. These results clearly suggest that Notch signaling is required for maintaining crypt cells in a proliferative state, at least in part, through its negative regulation of Math1. Conversely, conditional removal of the Notch pathway transcription factor CSL/RBP-J increases the proportion of goblet cells in the murine intestine, and a similar phenotype was observed using a γ-secretase inhibitor (van Es et al., 2005) . These results suggest that Notch pathway is not only a gatekeeper for proliferating crypt progenitor cells, but is also involved in controlling the balance between secretory and absorptive cell types. Data suggest that the ISC microenvironment delivers Notch-activating signals to maintain stemness, which is consistent with the observation that Paneth cells express Notch ligands (Sato et al., 2011) . In particular, recent papers identified Dll1 and Dll4 as the physiologically relevant Notch1 and Notch2 ligands within the small intestine of the mouse. These ligands cooperate and exhibit a partial functional redundancy to maintain the crypt progenitor compartment (Pellegrinet et al., 2011) . However, Notch seems to have dual functions in the crypt, as it acts together with Wnt to affect significantly crypt homeostasis (Fre et al., 2005; van Es et al., 2005) .
Canonical Wnt signaling in intestinal epithelium
The Wnt pathway proteins regulate cellular fate along the crypt-villus axis in normal gut epithelium and have been implicated in ISC self-renewal. The nuclear accumulation of β-catenin is preferentially observed in cells located at the base of crypts and decreases as cells move toward the top of the crypts (van der Wetering et al., 2002) . Wnt target genes EphB2 and EphB3 control crypt cellular segregation (Batlle et al., 2002) , Sox9 regulates Paneth cell differentiation (Mori-Akiyama et al., 2007) , and Lgr5 (Barker et al., 2007) . TCF4 null mice died shortly after birth and showed an embryonic epithelium made entirely of differentiated cells without proliferative compartments in the crypts (Korinek et al., 1998) suggesting that TCF4 maintains the proliferation of SCs in the murine small intestine. Notably, deletion of the Wnt/TCF4 target gene c-Myc led to a loss of intestinal crypts in a murine model (Muncan et al., 2006) . The importance of the Wnt signaling pathway in maintaining the architecture and homeostasis of the adult intestinal epithelium was also shown in a murine model through adenoviral expression of Dkk1. This induced Wnt inhibition in fully adult mice, resulted in inhibition of proliferation in the small intestine and colon, with progressive loss of crypts, villi and glandular structure (Kuhnert et al., 2004) . By contrast, when the Wnt pathway is overactivated by mutations in APC or β-catenin, many of the epithelial cells enter into the proliferative state and display a failure of the differentiation programs (Andreu et al., 2005; Sansom et al., 2004) . According with these data, recent papers demonstrated that injection of R-spondin1 (R-Spo1), a potent activator of the Wnt signaling pathways, induced rapid onset of crypt cell proliferation displaying epithelial hyperplasia in the intestine of normal mice through β-catenin stabilization and subsequent transcriptional a c t i v a t i o n o f t a r g e t g e n e s s u c h a s m u r i n e Axin2, Ascl2, and Lgr5 (Kim et al., 2005; Takashima et al., 2011) . The effects of R-Spo1 administration determine protection against radiation-induced colitis by stimulating proliferation of intestinal SCs and protect them against a damage after allogeneic bone-marrow transplantation, suppressing inflammatory cytokine cascades and donor T cell activation (Takashima et al., 2011) . These, in vivo, data suggest that Wnt signaling is directly linked to the promotion of cellular proliferation and, more specifically, the regulation of progression through cell cycle. In this regard, previous papers pointed to the downregulation of p21 cip1waf1 , a cyclin-dependent kinase inhibitor (CKI), as an important mechanism that might mediate Wnt-dependent growth promotion. A microarray analysis showed that p21 cip1waf1 was one of the genes whose expression was increased by inhibition of Wnt signaling in human colorectal cancer-derived LS174T cells (van der Wetering et al., 2002) . Furthermore, the TCF4 target gene c-Myc has been shown to play a central role in Wnt-mediated repression of p21 cip1waf1 expression at the transcriptional level through its direct binding to the p21 cip1waf1 gene promoter (van der Wetering et al., 2002) . These data suggest that the repression of p21 cip1waf1 by c-Myc might be the intracellular mechanism by which Wnt signaling regulates the G1/S transition and cell cycle progression. This signaling cascade has been shown to be functional in vivo, because abnormal features of proliferation/differentiation in the adult murine intestine, which occur with the single deletion of APC, are mostly rescued when c-Myc gene is simultaneously deleted (Sansom et al., 2007) . Furthermore, this restoration of the morphologically normal phenotype in double mutant mice for APC and c-Myc is accompanied by restoration of p21 expression within the crypts, suggesting the involvement of p21 in the Wnt-c-Myc pathwaymediated growth control of progenitor cells. Indeed, raises the possibility that p21 is an intracellular molecular switch between proliferation and differentiation. Moreover, it has been shown that conditional expression of p21 cip1waf1 alone allow cells to differentiate (van der Wetering et al., 2002) suggesting that the cell fate choice between proliferation and differentiation is regulated by modulation of the expression of p21 cip1waf1 via the direct induction of c-Myc by Wnt signaling. In general, the data strongly support a model in which Notch directs proliferation when Wnt signal activity is high, and directs enterocyte differentiation when Wnt activity levels drop towards the top of the crypt. The multipotent progenitors require both Wnt and Notch signals to be activated for fulfilling continuous proliferation without differentiation. Once some cells in this Wnt and Notch-activated population escape from the Notch signal, they stop proliferating and acquire the Math1 function. These cells raise the terminally differentiation in secretory cells in areas where the Wnt signal is not active (Pinto et al., 2003) , whereas they differentiate in Paneth cells if they remain at the bottom of the crypt where Wnt ligands are abundant. By contrast, if cells in this Wnt and Notch-active population lose the Wnt signal, for example, because of their positional changes along the vertical axis, they differentiate as absorptive cells (Fig. 5) .
SCs and the origin of intestinal cancer
Despite stringent homeostatic maintenance in the intestine, the high number of patients with colorectal cancer (CRC) indicates that these regulatory mechanisms often fall short in protecting against malignant transformation. Both environmental and genetic risk factors have been defined for CRC, and deregulation of morphogenetic pathways plays a key part in cancer development. Notably, the vast majority of sporadic CRC cases carry Wnt pathway mutations, highlighting the importance of this pathway in CRC. The hit that induces transition from normal to polypoid tissue is accompanied by several changes in crypt appearance and behavior, cells show a more immature phenotype and a higher proliferative index which results in expansion of the pre-malignant clone. Although mutation of APC or β-catenin is an early event in the transformation of colonic epithelial cells, studies have revealed that colon carcinomas do not contain nuclear β-catenin homogeneously (Fodde & Brabletz, 2007) . This so-called β-catenin paradox indicate that Wnt signaling has a preponderant role only for a subset of tumour cells, cancer SCs (CSCs), which are endowed with tumorigenic capacity (Vermeulen et al., 2008) . Indeed, the past decade has seen a shift in the way tumours are perceived, and the now widely accepted model is that tumours contain a small population of self-renewing CSCs, as well as a large compartment of more differentiated tumour cells (Vermeulen et al., 2008) . Cellular hierarchy within CRC is maintained, at least in part, by microenvironmental factors regulating stemness and differentiation. In agreement, tumour cells located next to myofibroblast-rich regions, have a much higher incidence of nuclear-localized β-catenin, suggesting for microenvironment-modulated Wnt signaling (Fodde & Brabletz, 2007) . A recent paper point to hepatocyte growth factor (HGF) as the myofibroblast-derived signal that, at least in part, orchestrates this intimate relationship and enhances Wnt activity in more differentiated tumour cells, thereby reinstalling CSCs features (dedifferentiation) (Vermeulen et al., 2010) . Indeed, using a TCF/LEF reporter that directs the expression of enhanced green fluorescent protein, authors provided evidence that Wnt signaling activity is a marker for colon CSCs and is regulated by the microenvironment. Moreover, they show that differentiated cancer cells can be reprogrammed to express CSC markers and regain their tumorigenic capacity when stimulated with myofibroblast-derived factors (Vermeulen et al., 2010) . Although, these data clearly ascertain a role for the Wnt pathway in CRC stemness, Notch inhibition with an antibody against the Notch ligand Dll4 results in human colon CSCs differentiation, reduction of CRC growth in a xenotransplantation model and chemosensitization (Hoey et al., 2009 ).
Identification of Renal SCs
The mammalian kidney shares with the majority of organs the ability to repopulate and at least partially repair structures that have sustained some degree of injury. Indeed, tubular integrity can be rescued after acute damage, and even severe glomerular disorders sometimes may undergo regression and remission, suggesting that glomerular injury is also reparable (Imai & Iwatani, 2007; Remuzzi, et al., 2006) . However, the existence of renal SC (RSC) has been a matter of long debate. Recently, converging data definitively demonstrated the existence of a population of stem/progenitor cells in the parietal epithelium of the Bowman's capsule of adult human kidney (Sagrinati, et al., 2006) (Fig.6 ). These SC coexpress both CD24, a surface molecule that has been used to identify different types of human SC, and CD133, a marker of several types of adult tissue SC, lack lineage-specific markers, express transcription factors that are characteristic of multipotent SC, and exhibit selfrenewal, high clonogenic efficiency and multidifferentiation potential. When injected intravenously in SCID mice that had acute kidney injury, RSC regenerated tubular structures from different portions of the nephron and also reduced the morphological and functional kidney damage (Sagrinati, et al., 2006) .
In addition, it was demonstrated that RSC are arranged in a precise sequence within Bowman's capsule of adult human kidneys (Fig. 6) . Fig. 6 . Localization of RPC in the glomerulus. RPC (green) are localized in the Bowman's capsule epithelium. A transitional cell population (podocyte progenitors, green/yellow) displays features of either RPC or podocyte (yellow) and localize between the urinary pole and the vascular stalk. Cells that express only podocyte markers and the phenotypic features of differentiated podocytes (yellow) localize at the vascular stalk of the glomerulus.
These findings obtained in human kidneys were confirmed in a parallel study performed in murine kidney by Appel (Appel, et al., 2009) , who also demonstrated the existence of transitional cells with morphological and immunohistochemical features of both parietal epithelial cells and podocyte in proximity of the glomerular vascular stalk and that podocytes are recruited from parietal epithelial cells, which proliferate and differentiate from the urinary to the vascular stalk, then generating novel podocytes (Fig. 6 ). This occurs as the kidney grows, during childhood and adolescence, and may also take place following an injury which allows a slow, regulated generation of novel podocytes, such as uninephrectomy. Recently, a rare subpopulation of CD133+CD24+ cells has also been describe in renal tubules (Lindgren, et al., 2011) . These cells are able to proliferate and differentiate after tubular injury. Accordingly, tubular epithelium regenerating on acute tubular necrosis displayed long stretches of CD133+CD24+ cells, further substantiating that the cells that are repairing tubular epithelium may simply represent the result of proliferation and differentiation of CD133+CD24+ tubular progenitors.
Involvement of RSC in glomerular disorders and cancer
It has been widely recognized that a disruption in the strictly regulated balance of SC selfrenewal and differentiation not only impairs regenerative mechanisms but can even generate disorders. In the glomerulus, the response to podocyte injury may cause aberrant epithelial cell proliferation, hypercellular lesions formation and Bowman's space obliteration, as seen in collapsing glomerulopathy and in crescentic glomerulonephritis (Albaqumi & Barisoni, 2008; Thorner, et al., 2008) . Until now, theories explaining the origin of aberrant epithelial cells in collapsing glomerulopathy and crescentic glomerulonephritis have been controversial. One possibility is that these cells are exclusively of parietal epithelial origin (Thorner et al., 2008 ) , while another is that some dedifferentiated podocytes acquire markers of parietal epithelial cells (Moeller et al., 2004) . It was recently demonstrated that the majority of cells present in the hyperplastic lesions in collapsing glomerulopathy or crescentic glomerulonephritis exhibits the RSC markers CD133 and CD24, with or without coexpression of podocyte markers . Therefore, it is suggested that the glomerular hyperplastic lesions are generated by RSC of Bowman's capsule at different stages of their differentiation towards mature podocytes. Support for this hypothesis came from lineage tracing experiments performed in transgenic mice with genetically labeled parietal epithelial cells in a model of inflammatory crescentic glomerulonephritis, and of collapsing glomerulopathy ).
Finally, a close relationship between the transcriptome of CD133+ tubular progenitors and the one derived by papillary renal cell carcinomas was demonstrated (Lindgren et al. 2011 ). Moreover, a strong CD133 expression was observed in the papillary renal cell carcinomas analysed. Thus, these observations raise the provocative hypothesis that papillary renal cell carcinomas may directly derive from CD133 + CD24 + renal tubular progenitors, whereas clear renal cell carcinomas may derive from other more differentiated proximal tubular cells.
Signaling pathway regulating the RSC niche
The molecular mechanisms regulating the proliferation of RSC, as well as the cell fate determination in the podocyte lineage are unknown. We recently demonstrate the role of the Notch signaling pathway in both these processes (Lasagni et al., 2010) . Notch activation triggers the expansion of renal progenitors by promoting their entry into the S-phase of the cell cycle and mitotic division. Moreover, Notch downregulation is required for differentiation toward the podocyte lineage. However, Notch downregulation was neither sufficient nor necessary for the acquisition of a podocyte phenotype, but an impaired downregulation of the Notch pathway led to podocyte death. Indeed, renal progenitor differentiation into podocytes was associated with cell cycle checkpoint activation and G 2 /M arrest, reflecting an intrinsic barrier to replication of mature podocytes. Persistent activation of the Notch pathway induced podocytes to cross the G 2 /M checkpoint, resulting in cytoskeleton disruption and cell death (Lasagni et al., 2010) . Notch expression was virtually absent in the glomeruli of healthy adult kidneys, while a strong upregulation was observed in renal progenitors and podocytes in patients affected by glomerular disorders. Accordingly, inhibition of the Notch pathway in mouse models of focal segmental glomerulosclerosis ameliorated proteinuria and reduced podocyte loss during the initial phases of glomerular injury, while inducing reduction of progenitor proliferation during the regenerative phases of glomerular injury with worsening of proteinuria and glomerulosclerosis. Taken altogether, these results suggest that the severity of glomerular disorders depends on the Notch-regulated balance between podocyte death and regeneration provided by renal progenitors (Lasagni et al., 2010) .
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